KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Capital Expenditures (2016 - 2025)

Zimmer Biomet Holdings has reported Capital Expenditures over the past 17 years, most recently at $74.8 million for Q4 2025.

  • Quarterly results put Capital Expenditures at $74.8 million for Q4 2025, up 45.24% from a year ago — trailing twelve months through Dec 2025 was $224.5 million (up 10.16% YoY), and the annual figure for FY2025 was $224.5 million, up 10.16%.
  • Capital Expenditures for Q4 2025 was $74.8 million at Zimmer Biomet Holdings, up from $55.0 million in the prior quarter.
  • Over the last five years, Capital Expenditures for ZBH hit a ceiling of $97.3 million in Q2 2023 and a floor of $24.6 million in Q2 2021.
  • Median Capital Expenditures over the past 5 years was $49.6 million (2021), compared with a mean of $52.5 million.
  • Biggest five-year swings in Capital Expenditures: soared 137.9% in 2023 and later plummeted 47.21% in 2024.
  • Zimmer Biomet Holdings' Capital Expenditures stood at $49.2 million in 2021, then increased by 28.86% to $63.4 million in 2022, then dropped by 0.95% to $62.8 million in 2023, then fell by 17.99% to $51.5 million in 2024, then skyrocketed by 45.24% to $74.8 million in 2025.
  • The last three reported values for Capital Expenditures were $74.8 million (Q4 2025), $55.0 million (Q3 2025), and $50.1 million (Q2 2025) per Business Quant data.